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Volume 56, Number 2 Abstracts 581included two early reocclusions (treated with reintervention). There were no
pulmonary embolisms or death.
Conclusions: Excellent 1-year patency rates and a significant reduction
in symptoms and CEAP class can be attained with percutaneous intervention
for MT syndrome. IVUS imaging is essential for accurate diagnosis and stent
sizing in patients with nonthrombotic MT syndrome.
Comparative Effectiveness of Endovascular and Open Surgical Revas-
cularization in Diabetic Patients With “Critical Limb Ischemia” (Ruth-
erford 5 and 6) Due to Severe Tibial Artery Occlusive Disease
Luke X. Zhan, MD, PhD, Magdiel Trinidad-Hernandez, MD,
David G. Armstrong, MD, PhD, DPM, and
Joseph L. Mills, Sr, MD. Department of Surgery, University of Arizona,
Tucson, Ariz
Objective: The original 1982 definition of “critical limb ischemia”
(CLI) excluded patients with diabetes. Although endovascular therapy
(ENDO) has become the dominant revascularization method, its effective-
ness for tibial disease compared with bypass surgery (OPEN) in diabetic
individuals with CLI is unclear. Assessment of revascularization outcomes is
difficult in diabetic patients due to neuropathy, wounds, and infection. We
evaluated and compared outcomes in such patients using validated risk
stratification schemes (Prevent III and FinnVasc) and the Society for Vas-
cular Surgery (SVS) objective performance goals (OPGs).
Methods: We studied 94 consecutive tibial/pedal interventions in 70
limbs of 59 diabetic patients (64% men) with CLI who initially underwent
ENDO (n  37) or OPEN (n  33). Mean age was 69 years, and all had
tissue loss (Rutherford 5-6). We evaluated Prevent III and FinnVasc scores
in both groups. We compared wound healing time (WHT) and major SVS
OPGs, including 1-year amputation-free survival rate, major adverse limb
events, and major adverse cardiac events.
Results: Prevent III and FinnVasc preintervention risk scores were
similar in both groups. Limb salvage rates and WHT were also comparable,
but there was a trend toward faster WHT for OPEN. There were no
significant differences between groups regarding amputation-free survival
rate, major adverse limb events, and major adverse cardiac events.
Conclusions: This is the first study to assess outcomes of tibial revas-
cularization in diabetic patients with CLI using current risk stratification
schemes and SVS OPGs. ENDO and OPEN both met the target 1-year
amputation-free survival SVS OPG of 70%, suggesting that with proper
selection, each therapy is efficacious. Existing risk factor stratification scores
are suboptimal predictors of amputation and major adverse events in such a
heterogeneous group of patients. Important variables that influence therapy and
outcomes, such as patient factors (functional status, life expectancy), wound
factors (presence, depth, and location), infection (presence, severity, and ex-
tent), conduit availability, target availability, and outflow are lacking, suggesting
the need for a new classification system for CLI in this growing subgroup.
Table. Risk stratification and comparison of outcomes
with Society for Vascular Surgery Objective Performance
Goals
Variable ENDO (N  37) OPEN (N  33) P
Prevent III, mean  SD 5.39  1.97 5.24  1.87 .7457
FinnVasc, mean  SD 2.16  0.83 2.52  0.91 .088
1 year AFS, % 83.8 69.7 .25
WHT, days (95% CI) 227.4 (177.3-277.5) 174.6 (132.3-216.9) .18
MALE, % 43.2 45.5 1
MACE, % 2.7 3.0 1
CI, confidence interval; MACE, Major adverse cardiac events; MALE, major
adverse limb events; SD, standard deviation; WHT, wound healing time.
Axillary Branch Artery Aneurysms: A Rare Cause of Upper Extremity
Ischemia in High-Performance Athletes
Jason T. Lee, MD, Venita Chandra, MD, Timothy McAdams, MD, and
Cornelius Olcott IV, MD. Division of Vascular Surgery, Stanford Univer-
sity Medical Center, Palo Alto, Calif
Objective: Axillary artery branch aneurysms (AABA) occur due to
extreme repetitive upper extremity effort and can result in hand ischemia
from embolic occlusion. Because these are found in otherwise healthy
high-performance athletes, the diagnosis is often missed or delayed. We
describe two cases of AABA resulting in thromboembolism and hand
ischemia in two nationally competitive athletes.
Methods: Preoperative imaging and perioperative findings were re-
viewed in two patients.
Results: A 57-year old senior United States Tennis Association player
in the national finals presented with right upper extremity paraesthesias
associated with diminished pulses and weakness after a vigorous match. The
p
matient underwent upper extremity angiography and subsequent thrombol-
sis, demonstrating a posterior circumflex humeral AABA (Fig 1, a) that had
mbolized to his wrist (Fig 1, b). Treatment with suture ligation (Fig 1, c)
nd anticoagulation allowed him to recover without recurrent ischemia, and he
layed in the national finals. A 17-year-old starting quarterback for a division I
ootball program noted progressive thumb pain and ischemia over the last four
ames of his freshman season, necessitating wearing gloves and placing his hand
n warm water after games. Angiography and computed tomography angiogra-
hy confirmed a similar AABA (Fig 2, a), and angiography confirmed emboli-
ation to digital arteries of the thumb (Fig 2, b). He was treated with anticoag-
lation and similar ligation to prevent future embolic events (Fig 2, c). He has
eturned to starting quarterback for his sophomore season.
Conclusions: These cases highlight AABAs resulting from recurrent
pper extremity trauma and subsequent thrombosis and embolism to the
and and wrist. Treatment entails thrombolysis or anticoagulation, or both,
nd then ligation of the branch to prevent future embolic potential. A high
ndex of suspicion for axillary artery pathology should be present when high
erformance athletes with repetitive overhead motions present with upper
xtremity arterial insufficiency.
ndoscopic Vein Harvest for Infra-inguinal Arterial Bypass
arah Wartman, MD, Gabriel Herscu, MD, Karen Woo, MD,
ichael Morell, Vahagn Nikolian, Miguel Manzur, and
red Weaver, MD. Keck Medical Center, University of Southern Califor-
ia, Los Angeles, Calif
Objective: Endoscopic harvest (EH) of saphenous vein for lower
xtremity bypass decreases length of incisions and was initially thought to
ecrease wound complication rates without adversely affecting patency.
owever, recent studies have shown lower patency without a wound com-
lication benefit. We sought to further study the wound complication and
atency rates of EH compared with open harvest (OH) techniques in
nfrainguinal arterial bypass procedures.
Methods: Infrainguinal bypasses performed between 2000 and 2011
ere analyzed. Only procedures using a single segment of great saphenous
ein were included. Patients were grouped according to EH or OH. The two
roups were frequency-matched for body mass index and diabetes. Baseline
haracteristics were compared. Univariate and multivariate analysis was
erformed, as appropriate, to determine correlation of baseline data and
arvest method on patency.
Results: The study included 76 bypasses: 35 in the EH group and 41
n the OH group. Baseline characteristics between the OH and EH groups
ere not significantly different. Mean age was 72 years in the EH group and
7 years in the OH group. The difference in the numbers of men and women
etween the two groups was not significant. Mean follow-up was 747 days.
here was no significant difference between the EH and OH groups in
0-day wound complication rates (29% vs 27%; P  .86), 3 year primary
atency rates (47% vs 49%, P .82), or 3 year primary assisted patency rates
88% vs. 76%, P .2). There was a trend toward increased secondary patency
n the EH group (92% vs 73%, P  .053). High body mass index improved
rimary patency (hazard ratio [HR], 0.89; 95% confidence interval [CI],
.82-0.97). Patients requiring hemodialysis had increased risk for loss of
rimary assisted patency (HR, 12.05; 95% CI 3.19-45.57) and secondary
Fig.atency (HR, 5.27; 95% CI 1.60-17.34). This remained significant on
ultivariate analysis when accounting for type of vein harvest.
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August 2012582 AbstractsConclusions: Overall, EH for infrainguinal arterial bypass confers no
additional benefit in wound complication or bypass patency rates compared
with OH. However, the possibility that bypass patency may be enhanced by
EH in the nonhemodialysis population deserves further study.
Outpatient Common Femoral Artery Stenting: Midterm Outcomes
Sam S. Ahn, MD, Monica J. Uceda, MD, Kenneth R. Kollmeyer, MD,
Craig A. Ferrara, DO, and Pablo V. Uceda, MD. DFW Vascular Group,
Dallas, Texas
Objective: Stenting of common femoral artery (CFA) lesions is con-
troversial. The purpose of this study was to demonstrate the safety, efficacy,
and midterm outcomes of CFA stenting.
Methods: From January 2009 to December 2011, 61 patients, 29 men
(48%) and 32 women, underwent CFA stenting in our outpatient office angio-
suite. Patients were a mean age of 67.28  9.85 years. The most common
comorbidities were hypertension (91.8%), smoking (59%), hyperlipidemia
(59%), and diabetes (39.34%). Indications for the procedure were moderate
claudication (4.35%), severe claudication (50.72%), ischemic rest pain
(37.68%), and nonhealing ulcer (7.25%). We retrospectively analyzed the out-
comes of 69 CFA lesions by evaluating clinical improvement and patency.
Results: Follow-up for clinical improvement showed 30 patients
(44.12%) achieved the “markedly improved” Rutherford classification,
14 (20.59%) were “moderately improved,” and the condition worsened
in seven (10.29%). The cumulative primary patency rate was 94% at 3
months, 82% at 6 months, 71% at 9 months, and 67% at 12 months,
remaining the same over 24 months. Cumulative primary assisted pa-
tency was 100% at 21 months. Thirteen cases (19%) were considered as
failures. Concomitant vascular stenting in other vessels was performed in
58 patients (83.82%). The only postoperative complication was a groin
hematoma in one patient (1.47%). Twenty stents (29.41%) subsequently
were punctured, without complications, to achieve access for other
endovascular procedures.
Conclusions: Stenting of CFA lesions with self-expandable stents is
safe and effective in the outpatient office setting. Puncturing the CFA stent
for subsequent endovascular access is also safe and effective.
Clinical Consequence of Bare-Metal Stent and Stent Graft Failure in
Femoropopliteal Occlusive Disease
Shant M. Vartanian,1 Paul J. Johnston,2 Joy P. Walker,1 Sara J. Runge,1
Charles M. Eichler,1 and Michael S. Conte1. 1University of California–San
Francisco, San Francisco, Calif; and 2Colorado Permanente Medical Group,
Denver, Colo
Objective: The optimal role for bare-metal stents (BMS) and stent
grafts (SG) in treating femoropopliteal occlusive disease (FPOD) is as yet
undefined. Understanding the clinical consequences of failure can help
guide initial treatment decisions. The goal of this study was to define the
nature and frequency of adverse clinical events related to BMS and SG failure
in FPOD.
Methods: This is a single-institution retrospective review of the pri-
Fig.mary endovascular intervention for FPOD, treated with BMS or SG, from
September 2007 through October 2011. Patient demographics, indications
(
ror intervention, anatomic characteristics, procedural details, clinical outcomes,
nd reintervention details were reviewed. Patients were excluded if they had any
revious lower extremity interventions or inadequate follow-up.
Results: Of the 127 limbs from 97 patients that met the inclusion
riteria, 67 were treated with BMS and 60 with SG. Follow-up averaged 551
ays for BMS and 690 days SG. The indication for intervention was similar
etween groups (49% vs 68% claudication; P  .15). Baseline patient
haracteristics were similar between groups, with the exception of more
ransAtlantic Inter-Society Consensus (TASC) D lesions (9 of 67 vs 26 of
0, P  .01) and chronic total occlusion (18 of 67 vs 35 of 60; P  .01) in
he SG group. Freedom from reintervention of the index procedure was
ore likely with SG (28 of 67 vs 40 of 60, P  .01). For both groups, the
ndications for reintervention of the index procedure were prompted by
hanges in symptoms or physical examination findings rather than by abnor-
al findings on surveillance ultrasound imaging (9 of 39 vs 3 of 20). Only
atients in the SG group presented with acute limb ischemia (0 vs 6, P 
01); however, the major adverse limb event rate was not different between
roups (11 vs 10, P .9). The 127 limbs needed 96 primary and secondary
nterventions during the course of the study. Including both primary and
econdary interventions, only patients treated with SG presented with acute
imb ischemia (0 vs 11, P  .1).
Conclusions: Reinterventions are common in both groups; however,
G failure is more likely to present with acute limb ischemia than BMS
ailure. These observations should be carefully considered when treating
POD with BMS or SG.
urgical Treatment of Lower Extremity Venous Aneurysms
rant T. Fankhauser, MD,1 William M. Stone, MD,1 Richard J. Fowl, MD,1
anju Kalra, MBBS,2 Peter Gloviczki, MD,2 W. Andrew Oldenburg, MD,3
nd Samuel R. Money, MD1. 1Division of Vascular Surgery, Mayo Clinic
rizona, Phoenix, Ariz; 2Mayo Clinic, Rochester, Minn; and 3Mayo Clinic
lorida, Jacksonville, Fla
Objective: Lower extremity venous aneurysms are rare. Their symp-
oms, diagnosis, and treatment are varied. The purpose of this study was to
eview our contemporary experience in managing these unusual entities and
efine the treatment options.
Methods: A retrospective review from 1994 to 2011 was conducted at
hree geographically separate institutions. Basic demographics, diagnostic
orkup, treatment, and follow-up were reviewed.
Results: The review included 14 patients with lower extremity venous
neurysms. There were four male patients (29%) and 10 female patients
71%), with a mean age of 46 years (range 14-74 years). The 14 aneurysms
onsisted of seven popliteal vein (50%), three great saphenous vein (21%),
wo small saphenous vein (14%), one common femoral vein (FV) (7%), and
ne FV (7%). Symptoms that led to the diagnosis were pain (n  6, 43%),
eep vein thrombosis (DVT; n  4, 29%), palpable mass (n  2, 14%),
neurysm rupture (n  1, 7%), and knee injury (n  1, 7%). Inferior vena
ava filters were placed preoperatively in two patients with pulmonary
mbolism from popliteal DVT. The five patients with great/small saphenous
ein aneurysms underwent excision. The 10 patients with popliteal, FV, or
ommon FV aneurysms underwent aneurysmectomy with venorrhaphy (n
), aneurysmectomy with interposition saphenous vein graft (n  4), or
neurysm excision with end-to-side anastomosis to the great saphenous vein
Fig.FV, n  1). Surgical complications included three (21%) hematomas
equiring surgical evacuation, two (14%) postoperative thromboses requir-
